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Objectives. We sought o assess the clinical outcome, functional 
status and complications of adult patients with congenitally 
corrected transposition of the great arteries. 
Background. Congenitally corrected transposition is a rare 
form of congenital heart disease, although survival into adult life 
may be expected. Little information is available on the long-term 
prognosis of these patients once they have reached adulthood. 
This study focuses exclusively on patients >18 years old followed 
up at a single tertiary referral center. 
Methods. The charts of all patients with a diagnosis of congen- 
itally corrected transposition ofthe great arteries from the Toronto 
Congenital Cardiac Centre for Adults since 1985 were reviewed. 
Data were available for 52 patients, 26 of whom had undergone 
radionuclide angiography. Mortality, clinical and functional sta- 
tus, surgical procedures and complications were reviewed. 
Results. Thirteen patients (25%) died; age at death was 38.5 +- 
12.5 years (mean _+ SD). The current age of survivors is 32.7 years 
(range 18.2 to 54.3). Of the survivors, 17 had palliative proce- 
dures, and 25 had definitive repair, 11 of whom required reopera- 
tion. Left ventricle to pulmonary artery conduit replacement was 
necessary in seven patients. Eighteen patients have permanent 
pacemakers, nine of whom developed complete heart block peri- 
operatively. Nine patients developed progressive atrioventricular 
(AV) block unrelated to operation. Supraventricular rhythmias 
occurred in 15 patients. Progressive systemic AV valve regurgita- 
tion developed in 10 patients and endocarditis in 6. 
Conclusions. Congenitally corrected transposition i  the adult 
patient is not a benign condition. Late complications are common 
and warrant careful, long-term follow-up. 
(J Am CoU Cardiol 1996;27:1238-43) 
Congenitally corrected transposition of the great arteries is a 
rare form of congenital heart disease first described by Von 
Rokitansky in 1875 (1). It accounts for <1% of all forms of 
congenital heart disease and is characterized byatrioventricu- 
lar (AV) and ventriculo-arterial discordance. Thus, the left 
ventricle supports the pulmonary circulation, and the right 
ventricle supports the systemic irculation. Recognizable asso- 
ciated abnormalities occur in 98% of cases (2) and include 
ventricular septal defect, pulmonary and subpulmonary steno- 
sis, abnormalities of the systemic (tricuspid) AV valve and 
complete AV block (3,4). Long-term survival is possible, 
particularly when there are no associated abnormalities (5,6). 
However, the long-term prognosis of these patients once they 
have reached adulthood, especially in the setting of associated 
abnormalities, i  less well documented. Although larger series 
reporting results in children and adults have been published 
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(7), the present study represents he experience of a single 
center with such patients and is, to our knowledge, the largest 
study to date of adult patients with congenitally corrected 
transposition of the great arteries. 
Methods  
Patients. The case records of all adult patients >18 years 
old seen at the Congenital Cardiac Centre for Adults in 
Toronto since 1985 who had a diagnosis of congenitally 
corrected transposition of the great vessels and two ventricles 
of adequate size, potentially suitable for biventricular repair, 
were reviewed. Fifty-eight patients (33 men) satisfied the 
criteria. Of these, six (three men) were lost to follow-up and 
are thus excluded from further analysis. For the remainder, 
case records, clinical reports and angiographic, echocardio- 
graphic, Holter monitoring and postmortem data, where avail- 
able, were reviewed. 
Radionuclide angiography. Twenty-six patients (13 men) 
underwent rest and exercise radionuclide angiography to as- 
sess ventricular function, as previously described (8). Before 
exercise testing, the patients received red blood cells labeled 
using the standard modified in vivo technique. Gated radionu- 
clide angiography using an Apex 409 Elscint camera was 
obtained at rest in three views (anterior, lateral and best septal, 
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Figure 1. Kaplan-Meier survival curve for all patients with congeni- 
tally corrected transposition. 
individualized according to anatomy). Patients were positioned 
supine with their feet in the peddles of an electrically braked 
cycle ergometer. Exercise began with a 1-min warmup hase 
against minimal resistance. The work load was progressively 
increased by 200 kpm every 3 min until symptom-limited 
maximal capacity was achieved. Leg fatigue was the reason for 
discontinuing exercise in all subjects. Imaging was performed 
during the final 2 min of each work load, when systolic blood 
pressure and heart rate had reached a plateau. Results are 
compared with a group of sedentary, nonathletic normal men 
studied in our laboratory. 
Statistics. For statistical analysis of continuous variables, 
the Student t test was used. For analysis of categoric data, the 
Fisher exact test was used. Survival analysis was performed 
using the Kaplan-Meier method. A p value <0.05 was consid- 
ered statistically significant. 
Results 
Mortality. Thirteen (25%) of the 52 patients died, but 
follow-up data was only available in 11. Although 10 of these 
were men, male gender itself was not a risk factor for death 
(p -- 0.095). Figure 1 shows the Kaplan-Meier survival curve 
for the study group. Age of death was 38.5 _+ 12.5 years 
(mean _+ SD). Five patients died of progressive heart failure; 
four died suddenly (three after hospital discharge, one post- 
operatively); one had intractable Staphylococcus aureus endo- 
carditis; and one with severe biventricular failure died during 
transplantation surgery. 
Three patients died in the immediate postoperative p riod, 
one after closure of a ventricular septal defect and insertion of 
a left ventricle to pulmonary artery conduit. His initial post- 
operative course was unremarkable until he suddenly became 
hypotensive and developed electromechanical dissociation. 
Resuscitation was unsuccessful. A second patient who died 
early after operation had severe systemic (morphologic right) 
ventricular dysfunction. The patient chose an arterial switch 
plus a Mustard repair over transplantation. At the time of 
preparatory pulmonary artery banding, he developed severe 
morphologic left ventricular failure. Despite removal of the 
PS SD 
t 
Systemic AV valve 
abnormality 
Figure 2. Associated abnormalities n urviving patients. AV = atrio- 
ventricular; PS = pulmonary stenosis; VSD = ventricular septal 
defect. 
band, he did not regain ventricular function. He remained in 
intractable heart failure and died. The circumstances sur- 
rounding the third postoperative d ath are unknown. 
Of the four patients who died suddenly, only one had a 
permanent pacemaker in situ. However, two of the four 
patients had previous atrial arrhythmias, and one had polymor- 
phic ventricular ectopic activity on Holter monitoring. Of the 
13 patients who died, 7 had previous atrial arrhythmias, 1 had 
nonsustained ventricular tachycardia on Holter monitoring, 
and 1 had frequent ventricular ectopic beats. Thus, 69% of 
these patients were known to have some form of rhythm 
disturbance. 
Survivors. Thirty-nine patients (20 men) remain alive at 
last follow-up. Associated abnormalities in these patients are 
shown in Figure 2. The current age of the patients i 32.7 years 
(range 18.2 to 54.3). Only one patient has no associated 
abnormalities. 
Surgical repair (excluding pacemaker implantation) was not 
undertaken i 12 patients, although 1 is currently awaiting 
systemic AV valve replacement surgery. Seventeen of the 
patients underwent a total of 28 palliative shunts, as shown in 
Table 1. No patient received more than four palliative proce- 
dures. 
Twenty-five of the patients had some form of definitive 
repair. One patient had ventricular septal defect closure only. 
In 20 patients, conduits were placed between the morphologic 
left ventricle and pulmonary artery, and in 6 patients, ystemic 
(morphologic tricuspid) AV valve replacement was performed. 
Table 1, Palliative Procedures Undertaken in 17 Surviving Patients 
No. of Procedures 
Blalock-Taussig shunt 19 
Potts shunt 4 
Waterston shunt 2 
Aortopulmonary interposition shunt 2 
Glenn shunt 1 
Total 28 
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Figure 3. Prevalence of atrial arrhythmias, pacemaker insertion and 
sudden cardiac death in survivors and deceased patients. 
In two patients who underwent this latter procedure, severe 
systemic AV valve regurgitation developed after placement of 
the left ventricle to pulmonary artery conduit, despite insignif- 
icant AV valve regurgitation before the original procedure. 
Two patients had surgical palliation but were not considered 
suitable for definitive repair. Reoperation after repair oc- 
curred in 11 patients, with conduit replacement in 7. One 
patient had two conduit replacements. Conduits were replaced 
because of stenosis in six patients (1 to 12 years after original 
implantation), elective enlargement in one and endocarditis 
associated with false aneurysm in one. 
Figure 3 shows the prevalence of rhythm disturbances in
survivors and nonsurvivors. Pacemaker insertion was necessary 
in 18 patients (48%), even though only three (8%) patients had 
complete AV block at the time of diagnosis. In nine patients 
(23%), complete heart block occurred at the time of definitive 
repair, despite knowledge of the location of the conducting 
system and the care that was taken in placing the sutures. Six 
patients developed progressive AV block unrelated to opera- 
tion and required permanent pacing. Pacemaker revision is not 
infrequent: Figure 4 shows the number of pacemakers inserted 
Figure 4. Diagram showing the number of pacemakers implanted in
surviving patients with congenitally corrected transposition f the great 
arteries. 
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Figure 5. Prevalence of systemic atrioventricular valve regurgitation 
(SAWR [hatched area = moderate r gurgitation; open area = severe 
regurgitation]), endocarditis and systemic ventricular failure. 
in the 39 surviving patients. Eighteen of the patients currently 
have pacemakers: 10 in DDD mode, 5 in VVI mode and 3 in 
VVIR mode. In addition to AV block, atrial arrhythrnias have 
been documented in 15 survivors (38%) and include atrial 
fibrillation (9 patients), atrial flutter (2 patients, 1of whom also 
had atrial fibrillation) and supraventricular tachycardia (5 
patients). 
Figure 5 compares the prevalence of systemic AV valve 
regurgitation, endocarditis and systemic ventricular failure 
between the surviving and nonsurviving patients. Systemic 
(tricuspid) AV valve regurgitation, graded echocardiographi- 
cally as moderately severe (6 patients) or severe (4 patients), 
developed in 10 survivors (26%), 1 of whom is awaiting AV 
valve replacement. 
A total of six episodes of endocarditis occurred (11% of 
patients), two in patients who subsequently died (one because 
of intractable ndocarditis; the other recovered eventually 
after cranial surgery to drain cerebral abscesses that developed 
as a result of his endocarditis, although he later died during 
cardiac surgery at a site remote from his endocarditis). One 
episode of endocarditis was related to surgery. 
Of the 39 surviving patients, 3were admitted with episodes 
of heart failure. Two of these episodes were in women and 
occurred during pregnancy. Both were managed successfully 
with medical therapy and had successful outcomes to their 
pregnancies. 
Exercise performance, as assessed by supine bicycle ergom- 
etry with associated radionuclide ventriculography, was under- 
taken in 26 patients (13 men). The results are shown in Table 
2 and Figure 6 and are compared with those for normal control 
subjects tudied in our laboratory. There was no significant 
difference in the age of the control subjects and the age of the 
patients. Although all the control subjects were men and the 
patients both men and women, there was no significant differ- 
ence between the male and female patients in exercise perfor- 
mance. There is a significant reduction (p < 0.001) in exercise 
performance (maximal work load) and systemic ventricular 
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Table 2. Exercise Performance and Ejection Fraction in Patients With Congenitally Corrected 
Transposition and Normal Subjects 
Pts With c-TGA Normal Subjects 
[mean (--SD)] [mean (_+SD)] p Value 
Work load (kpm) 423.0 (183) 1,116.0 (190) < 0.001 
Exercise HR (beats/rain) 121.6 (28.9) 178.0 (18.3) < 0.001 
Rest SBP (mm Hg) 112.0 (11.2) 118.3 (12.6) NS 
Exercise SBP (mm Hg) 155.4 (26) 189.4 (21.5) < 0.05 
Rest SVEF (%) 44.3 (12.9) 59.9 (8.7) < 0.001 
Exercise SVEF (%) 42.9 (11.4) 70.6 (7.7) < 0.001 
c-TGA = congenitally corrected transposition of the great arteries; HR = heart rate; Pts = patients; SBP = systolic 
blood pressure; SVEF = systemic ventricular ejection fraction. 
ejection fraction (at rest and during exercise) when patients 
were compared with normal individuals. Likewise, maximal 
heart rate and maximal systolic blood pressure were reduced. 
It is not clear whether this is related to the reduced exercise 
time. In contrast o the rise in ejection fraction seen with 
exercise in normal subjects (58% at rest to 69.5% with exercise), 
there was no significant change in the patients with congenitally 
corrected transposition (43.3% to 42.9%). Although venous ven- 
tricular ejection fraction was not measured inthe control subjects, 
the values obtained from the patients were not significantly 
different from those available in the published ata (9). 
Discuss ion  
Congenitally corrected transposition is a rare cardiac mal- 
formation, accounting for -1% of congenital heart disease. 
Associated abnormalities are common, and the findings of 
pulmonary stenosis (74%), ventricular septal defect (74%), 
systemic (tricuspid) AV valve abnormalities (38%) and con- 
genital complete heart block (5%) in our series are in accord- 
ance with previously reported pediatric and combined pediat- 
ric/adult series as well as postmortem series (2,7,10). The 
present study focused only on adult patients >18 years old 
followed up at a single tertiary referral center. The high 
mortality rate (25%) in this series and the relatively oung age 
of death (mean 38.5 yr) demonstrate hat life expectancy in
these patients is far from normal. Although long-term survival 
Figure 6. Box plot of systemic ventricular ejection fraction (SVEF) in 
normal subjects and patients. Data shown are median (bold horizontal 







in patients with congenitally corrected transposition is possible, 
it is exceptional nd tends to occur in those patients without 
associated abnormalities and in whom no operation has been 
undertaken (5,6,11). Indeed, the oldest patient in this series, 
who died at age 61 years, was one such patient. Clearly, the 
presence of associated abnormalities confers mortality at a 
younger age. 
Concern has been expressed as to whether the morphologic 
right ventricle can support he systemic irculation over pro- 
longed periods in adult life (12), although this concern is not 
universal (13). Nevertheless, ystemic ventricular failure was 
the cause of death in >50% of the patients who died in the 
present series. In most cases, there was associated severe 
systemic AV valve regurgitation. However, it is not clear 
whether this was a cause of the ventricular deterioration or 
consequent toit, although it has been noted in patients with no 
associated anomalies that systemic AV valve regurgitation 
tends to precede ventricular dysfunction (11). It is not known 
whether this remains true in the presence of associated anom- 
alies. Nevertheless, the combination of poor ventricular func- 
tion and systemic AV valve regurgitation should be viewed 
with concern and appears to be a marker of poor outcome. 
Systemic ventricular function, as assessed by radionuclide 
angiography, is significantly impaired in patients with congen- 
itally corrected transposition compared with that in normal 
subjects. Ejection fraction at rest and during exercise is signif- 
icantly lower than normal in such patients and fails to increase 
with exercise. In patients with congenitally corrected transpo- 
sition, the systemic ventricle is morphologically the right 
ventricle, and it might be argued that the right ventricle 
normally operates at a lower ejection fraction than the left 
ventricle. Indeed, the rest ejection fraction in our series is 
similar to that found by Benson et al. (8), who studied 
ventricular function in congenitally corrected transposition. 
However, the lack of an increase in ejection fraction with 
exercise compared with the previous report (8) may be a 
reflection of the younger group studied (mean age 19.8 years 
vs. 32.7 years in our group). In addition, in patients who have 
undergone the Mustard procedure the right ventricle supports 
the systemic irculation, and rest ejection fraction is compara- 
ble with that found here (46.4% vs. 44.3%) (14,15). Again, 
however, in that younger Mustard group (mean age 21.5 yr), 
Rest Exercise Rest  Exercise 
Patients Normal 
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systemic ventricular ejection fraction increases to 57.1% with 
exercise. This finding lends support o the idea of the reduced 
ability of the right ventricle to support he systemic irculation 
over a normal ife span. It may well be that one manifestation 
of deteriorating ventricular function is the failure of ejection 
fraction to increase with exercise. 
Much emphasis has been placed on the presence of AV 
block in patients with congenitally corrected transposition (16), 
and it is recognized that progression of AV block occurs at the 
rate of 2%/year. The anatomic basis for this block has been 
well described with an abnormally placed AV node (17,18). 
Thus, it is perhaps not surprising that pacemakers were 
implanted in 46% of patients in the present series. However, 
50% of these patients required insertion of their pacemaker in
the perioperative period for complete heart block induced at 
the time of operation, despite knowledge of the conduction 
system and the care taken to avoid placing sutures near the 
bundle. It is known that fibrosis of the elongated AV bundle is 
common, particularly with older age (19), and it may be that 
the cooling and cardioplegia re sutficient to damage the 
already fragile conducting system. 
Replacement of pacemakers remains a concern: 50% of 
those patients with pacemakers have already required a re- 
placement, and 17% (3 of 18) are on their fourth system. The 
optimal pacing modality has clearly not yet been defined, as 
can be seen from the distribution of modalities chosen. How- 
ever, dual-chamber pacing is currently the most popular mo- 
dality used at revision of the pacing systems. 
A surprising finding in our series was the high incidence of 
atrial tachyarrhythmias. Thirty-six percent of the survivors 
have had documented atrial fibrillation, atrial flutter or su- 
praventricular tachycardia. Two of four patients who died 
suddenly and three of five patients who died of ventricular 
failure were previously known to have had atrial arrbythmias. 
In patients with congenitally corrected transposition and no 
associated anomalies, the onset of atrial arrhythmias i  not 
seen until the fifth decade (11), much later than the patients in 
the present report. It may be that the presence of associated 
abnormalities confers an increased risk for atrial arrhythmias 
with the greater prevalence of systemic AV valve regurgitation 
and ventricular dysfunction. Nevertheless, atrial arrhythmias 
are potentially detrimental insuch patients and should be dealt 
with expeditiously. 
Surgical intervention in adult patients with congenitally 
corrected transposition is common: 69% of patients in the 
present series have had intervention in the form of either a 
palliative shunt or a definitive repair. Forty-four percent have 
undergone palliative procedures, often multiple, and 64% have 
had either primary definitive repair or definitive repair after 
prior palliation. The most common form of definitive repair 
involved closure of a ventricular septal defect and a concomi- 
tant left ventricle to pulmonary artery conduit. As has been 
previously recognized (20), however, severe systemic AV valve 
regurgitation may develop for no apparent reason after this 
procedure and in our series necessitated replacement in two 
patients (10%), a lower proportion than previously described. 
Systemic AV valve repair was attempted in only one patient, 
who subsequently required valve replacement. In all but one 
patient who had systemic AV valve replacement, mechanical 
valves were used, necessitating lifelong anticoagulation. Pro- 
gressive systemic AV valve regurgitation remains a concern. 
Already, six (15%) survivors required valve replacement. An- 
other 10 (25%) have at least moderate regurgitation, as shown 
echocardiographically. It is likely that some of these patients 
will need valve replacement in the future. 
An unexpectedly high proportion of patients in the present 
series have had endocarditis (10% of survivors, 15% of non- 
survivors), emphasizing the need for antibiotic prophylaxis. 
Heart failure in pregnancy occurred in two patients. In both 
patients, medical management was successful, although one 
subsequently had systemic AV valve replacement. Careful 
monitoring throughout pregnancy is advisable. 
Study limitations. Clearly there are limitations to this 
study. The patients were highly selected because they were 
followed at a tertiary referral center. There is undoubtedly an 
underrepresentation of patients with no associated abnormal- 
ities who are asymptomatic and thus have not presented to 
medical attention. Nevertheless, the spectrum represented 
here is likely to be similar to that found at other large centers 
dealing with adult congenital heart disease. The numbers are 
still small, however, because of the rarity of the condition, and 
collaborative r search should be undertaken. 
Conclusions. Adult patients with congenitally corrected 
transposition are prone to progressive systemic AV valve 
regurgitation, rhythm disturbances (heart block and atrial 
arrhythmias), a high incidence of endocarditis and systemic 
ventricular dysfunction. The presence of associated abnormal- 
ities is associated with a high attrition rate in adult life. Repeat 
cardiac surgery and multiple pacemaker implantations are 
common, and careful follow-up is imperative. 
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